Loading...

Probi AB (publ)

PBBIF•PNK
Healthcare
Biotechnology
$24.00
$0.00(0.00%)

Probi AB (publ) (PBBIF) Stock Overview

Explore Probi AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap286.9M
P/E Ratio266.25
EPS (TTM)$0.09
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Week$24.00
1 Month$24.37
3 Months$34.15
1 Year Target$20.50

PBBIF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Probi AB (publ) (PBBIF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $20.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 266.25 and a market capitalization of 286.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;